Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$42.05 - $47.77 $5,130 - $5,827
-122 Reduced 0.72%
16,751 $729,000
Q1 2022

May 13, 2022

SELL
$40.23 - $47.74 $21,482 - $25,493
-534 Reduced 3.07%
16,873 $735,000
Q4 2021

Feb 11, 2022

SELL
$38.88 - $45.31 $5,520 - $6,434
-142 Reduced 0.81%
17,407 $768,000
Q3 2021

Nov 15, 2021

SELL
$38.79 - $43.16 $14,041 - $15,623
-362 Reduced 2.02%
17,549 $671,000
Q2 2021

Aug 09, 2021

SELL
$36.52 - $41.46 $16,434 - $18,657
-450 Reduced 2.45%
17,911 $713,000
Q1 2021

May 05, 2021

BUY
$34.27 - $40.01 $5,723 - $6,681
167 Added 0.92%
18,361 $655,000
Q4 2020

Feb 10, 2021

SELL
$34.07 - $39.94 $25,654 - $30,074
-753 Reduced 3.97%
18,194 $670,000
Q3 2020

Nov 05, 2020

SELL
$38.11 - $42.99 $91,730 - $103,476
-2,407 Reduced 11.27%
18,947 $693,000
Q2 2020

Aug 18, 2020

SELL
$37.87 - $43.58 $20,374 - $23,446
-538 Reduced 2.46%
21,354 $874,000
Q1 2020

May 20, 2020

SELL
$32.47 - $48.83 $139,556 - $209,871
-4,298 Reduced 16.41%
21,892 $924,000
Q4 2019

Jan 23, 2020

BUY
$42.0 - $48.25 $3,192 - $3,667
76 Added 0.29%
26,190 $1.23 Million
Q3 2019

Nov 14, 2019

SELL
$40.46 - $43.52 $54,621 - $58,752
-1,350 Reduced 4.92%
26,114 $1.16 Million
Q2 2019

Aug 13, 2019

SELL
$39.4 - $42.7 $14,381 - $15,585
-365 Reduced 1.31%
27,464 $1.15 Million
Q1 2019

May 15, 2019

SELL
$38.57 - $42.69 $445,174 - $492,727
-11,542 Reduced 29.32%
27,829 $1.13 Million
Q4 2018

Feb 14, 2019

BUY
$37.8 - $42.69 $4,687 - $5,293
124 Added 0.32%
39,371 $1.5 Million
Q3 2018

Nov 14, 2018

BUY
$39.75 - $42.69 $451,957 - $485,385
11,370 Added 40.79%
39,247 $1.58 Million
Q2 2018

Aug 10, 2018

SELL
$39.61 - $42.76 $15,883 - $17,146
-401 Reduced 1.42%
27,877 $1.12 Million
Q1 2018

May 15, 2018

BUY
$36.18 - $40.15 $1.02 Million - $1.14 Million
28,278 New
28,278 $1.11 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $67.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Signet Financial Management, LLC Portfolio

Follow Signet Financial Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Financial Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signet Financial Management, LLC with notifications on news.